(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of 20.55% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.56%.
Mdxhealth Sa's revenue in 2025 is $90,049,000.On average, 2 Wall Street analysts forecast MDXH's revenue for 2025 to be $5,372,935,606, with the lowest MDXH revenue forecast at $5,350,661,805, and the highest MDXH revenue forecast at $5,395,209,406.
In 2026, MDXH is forecast to generate $6,192,611,457 in revenue, with the lowest revenue forecast at $6,187,166,750 and the highest revenue forecast at $6,198,056,163.